www.thelancet.com Vol 378 August 27, 2011
29 US Census Bureau. US population projections. http://www.census.
gov/population/www/projections (accessed Aug 1, 2011).
30 Oﬃ ce for N
ational Statistics. National projections. http://www.
statistics.gov.uk/cci/nugget.asp?id=1352 (accessed Aug 1, 2011).
31 National Institues of Health—National Heart, Lung, and Blood
Institute. Incidence and prevalence: 2006 chart book on
cardiovascular and lung diseases, 2006. http://www.nhlbi.nih.gov/
resources/docs/06a_ip_chtbk.pdf (accessed Aug 1, 2011).
32 Preis SR, Pencina MJ, Hwang SJ, et al. Trends in cardiovascular
disease risk factors in individuals with and without diabetes in the
Framingham Heart Study. Circulation 2009; 120: 212–220.
33 Allender S, Scarborough P, Peto V, et al. European cardiovascular
disease statistics 2008. European Heart Network, 2008. http://www.
(accessed Jan 10, 2011).
34 Centers for Disease Control and Prevention. National health interview
survey. http://www.cdc.gov/nchs/nhis.htm (accessed Aug 1, 2011).
35 Scarborough P, Peto V, Bhatnagar P, et al. UK: stroke statistics,
2009 edition. London: British Heart Foundation, 2009.
36 CancerStats. Incidence 2008, UK. Cancer Research UK. 2011. http://
Aug 1, 2011).
37 Sun J, Gooch K, Svenson LW, Bell NP, Frank C. Estimating
osteoarthritis incidence from population-based administrative
health care databases. Ann Epidemiol 2007; 17: 51–56.
38 Lobstein T, Leach RJ. Data documentation for the Dynamic
Modelling for Health Impact Assessment (DYNAMO-HIA) Project.
Workpackage 7: Overweight and obesity report on data collection for
overweight and obesity prevalence and related relative risks.
London: International Association for the Study of Obesity, 2010.
39 Lloyd-Jones D, Adams R, Carnethon M, et al, for the American
Heart Association Statistics Committee and Stroke Statistics
Subcommittee. Heart disease and stroke statistics—2009 update: a
report from the American Heart Association Statistics Committee
and Stroke Statistics Subcommittee. Circulation 2009; 119: 480–86.
40 Scarborogh P, Bhatnagar P, Wickramasinghe K, Smolina K,
Mitchell C, Rayner M. Coronary heart statistics 2009 edition.
London: British Heart Foundation, 2009.
41 Schwartz MB, Puhl R. Childhood obesity: a societal problem
to solve. Obes Rev 2003; 4: 57–71.
42 The Health and Social Care Information Centre. Prescribing for
diabetes in England: 2004/05 to 2009/10. http://www.ic.nhs.uk/
pubs/prescribingdiabetes0410 (accessed Aug 1, 2011).
43 Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer:
economic cost and quality of life. Annu Rev Public Health 2001;
44 Soni A. MEPS Statistical Brief #22. Arthritis: use and expenditures
among U.S. adults noninstitutionalized population, 2005. Agency
for Healthcare Research and Quality, 2008. (http://www.meps.ahrq.
gov/mepsweb/data_ﬁ les/publications/st222/stat222.pdf accessed
Feb 1, 2011).
45 Finkelstein EA, DiBonaventura M, Burgess SM, Hale BC. The costs
of obesity in the workplace. J Occup Environ Med 2010; 52: 971–76.
46 Butland B, Jebb S, Kopelman P, et al. Foresight.Tackling obesities:
future choices—project report. London: Government Oﬃ ce for
47 McPherson K, Marsh T, Brown M. Foresight. Tackling obesities:
future choices—modelling future trends in obesity & their impact
on health. London: Government Oﬃ ce for Science, 2007.
48 Fishman GS. Monte Carlo: concepts, algorithms, and applications.
New York: Springer, 1995.
49 Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and
trends in obesity among US adults, 1999–2008. JAMA 2010;
50 Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM.
Prevalence of high body mass index in US children and
adolescents, 2007–2008. JAMA 2010; 303: 242–49.
51 Wang YC, Colditz GA, Kuntz KM. Forecasting the obesity epidemic
in the aging U.S. population. Obesity (Silver Spring) 2007;
52 Hall KD, Sacks G, Chandramohan D, et al. Quantiﬁ cation of the
eﬀ ect of energy imbalence on body weight change. Lancet 2011;
53 Lee RH. Future costs in cost eﬀ ectiveness analysis. J Health Econ
Rappange DR, van Baal PHM, van Excel NJA, Feenstra TL,
utten FFH, Brouwer WBF. Unrelated medical costs in life-years
gained: should they be included in economic evaluations of
healthcare interventions? Pharmacoeconomics 2008; 26: 815–30.
55 van Baal PHM, Polder JJ, de Wit GA, et al. Lifetime medical costs of
obesity: prevention no cure for increasing health expenditure.
PLoS Med 2008; 5: e29.
56 McPherson K. Does preventing obesity lead to reduced health-care
costs? PLoS Med 2008; 5: e37.
57 Finkelstein EA, Trogdon JG, Brown DS, Allaire BT, Dellea PS,
Kamal-Bahl SJ. The lifetime medical cost burden of overweight and
obesity: implications for obesity prevention. Obesity (Silver Spring)
2008; 16: 1843–48.
58 Garber AM, Phelps CE. Economic foundations of cost-eﬀ ectiveness
analysis. J Health Econ 1997; 16: 1–31.
59 Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic:
global drivers and local environments. Lancet 2011; 378: 804–14.
60 Colditz GA. Economic costs of obesity and inactivity.
Med Sci Sports Exer 1999; 31 (suppl 11): S663–67.
61 Oster G, Edelsberg J, O’Sullivan AK, Thompson D. The clinical
and economic burden of obesity in a managed care setting.
Am J Manag Care 2000; 6: 681–89.
62 Schmid A, Schneider H, Golay A, Keller U. Economic burden of
obesity and its comorbidities in Switzerland. Soz Praventivmed
2005; 50: 87–94.
63 Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign
prostatic hyperplasia. Am J Epidemiol 1994; 140: 989–1002.
64 Rich-Edwards JW, Garland MT, Hunter DJ, et al. Physical activity,
body mass index, and ovulatory disorder infertility. Epidemiology
2002; 13: 184–90.
65 Camargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE.
Prospective study of body mass index, weight change, and risk of
adult-onset asthma in women. Arch Intern Med 1999; 159: 2582–88.
66 Camargo CA, Wentowski CC, Field A, Gillman M, Frazier AA,
Colditz GA. Prospective cohort study of body mass index and risk
of asthma in children. Ann Epidemiol 2003; 13: 565.
67 Rössner S, Lagerstrand L, Persson HE, Sachs C. The sleep apnoea
syndrome in obesity: risk of sudden death. J Intern Med 1991;
68 Bell JF, Zimmerman FJ, Arterburn DE, Maciejewski ML.
Health-care expenditures of overweight and obese males and
females in the medical expenditures panel survey by age cohort.
Obesity (Silver Spring) 2011; 19: 228–32.
69 Colditz GA. Economic costs of obesity. Am J Clin Nutr 1992;
55 (suppl 2): S503–07.
70 Finkelstein EA, Ruhm CJ, Kosa KM. Economic causes and
consequences of obesity
. Ann Rev Public H
ealth 2005; 26: 239–57.
71 McCormick B, Stone I, for the Corporate Analytical Team.
Economic costs of obesity and the case for government
intervention. Obes Rev 2007; 8 (suppl 1): 161–64.
72 Andreyeva TA, Sturm RA, Ringel JS. Moderate and severe obesity
have large diﬀ erences in health care costs. Obes Res 2004;
73 Tirosh A, Shai I, Afek A, et al. Adolescent BMI trajectory and risk of
diabetes versus coronary disease. N Engl J Med 2011; 364: 1315–25.
74 Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J,
Goldman L. Adolescent overweight and future adult coronary heart
disease. N Engl J Med 2007; 357: 2371–79.
75 Roux L, Donaldson C. Economics and obesity: costing the problem
or evaluating solutions? Obes Res 2004; 12: 173–79.
76 Carter R, Moodie M, Markwick A, et al. Assessing cost-eﬀ ectiveness
in obesity (ACE-obesity): an overview of the ACE approach,
economic methods and cost results. BMC Public Health 2009; 9: 419.
77 Gortmaker SL, Swinburn BA, Levy D, et al. Changing the future of
obesity: science, policy, and action. Lancet 2011; 378: 838–47.
78 Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V,
Chisholm D. Tackling of unhealthy diets, physical inactivity, and
obesity: health eﬀ ects and cost-eﬀ ectiveness. Lancet 2010;